MARTINS ADEOYE: Open Payments
NPI 1962431726 · ORLAND PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,023 in 88 payments from 22 companies in 2025. Trend: 2023 $101 · 2024 $1,766 · 2025 $2,023
Food & beverage: $1,823Consulting: $200
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $383 |
| Janssen Pharmaceuticals, Inc | 13 | $250 |
| Janssen Scientific Affairs, LLC | 1 | $200 |
| Alkermes, Inc. | 7 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $125 |
| Indivior Inc. | 5 | $114 |
| Supernus Pharmaceuticals, Inc. | 4 | $92 |
| E.R. Squibb & Sons, L.L.C. | 4 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $83 |
| Corium, LLC | 5 | $80 |
Products named: REXULTI, SPRAVATO, CAPLYTA, ARISTADA, SUBLOCADE, INVEGA SUSTENNA, Qelbree, COBENFY.
Industry payments across IL — which companies pay providers there.
